149 related articles for article (PubMed ID: 28362391)
1. Absolute Quantification of Aβ1-42 in CSF Using a Mass Spectrometric Reference Measurement Procedure.
Pannee J; Blennow K; Zetterberg H; Portelius E
J Vis Exp; 2017 Mar; (121):. PubMed ID: 28362391
[TBL] [Abstract][Full Text] [Related]
2. An UHPLC-MS/MS method for simultaneous quantification of human amyloid beta peptides Aβ1-38, Aβ1-40 and Aβ1-42 in cerebrospinal fluid using micro-elution solid phase extraction.
Lin PP; Chen WL; Yuan F; Sheng L; Wu YJ; Zhang WW; Li GQ; Xu HR; Li XN
J Chromatogr B Analyt Technol Biomed Life Sci; 2017 Dec; 1070():82-91. PubMed ID: 29102244
[TBL] [Abstract][Full Text] [Related]
3. Preanalytical approaches to improve recovery of amyloid-β peptides from CSF as measured by immunological or mass spectrometry-based assays.
Schauer SP; Mylott WR; Yuan M; Jenkins RG; Rodney Mathews W; Honigberg LA; Wildsmith KR
Alzheimers Res Ther; 2018 Nov; 10(1):118. PubMed ID: 30486870
[TBL] [Abstract][Full Text] [Related]
4. Mass spectrometry-based candidate reference measurement procedure for quantification of amyloid-β in cerebrospinal fluid.
Leinenbach A; Pannee J; Dülffer T; Huber A; Bittner T; Andreasson U; Gobom J; Zetterberg H; Kobold U; Portelius E; Blennow K;
Clin Chem; 2014 Jul; 60(7):987-94. PubMed ID: 24842955
[TBL] [Abstract][Full Text] [Related]
5. Isobaric Quantification of Cerebrospinal Fluid Amyloid-β Peptides in Alzheimer's Disease: C-Terminal Truncation Relates to Early Measures of Neurodegeneration.
Rogeberg M; Almdahl IS; Wettergreen M; Nilsson LN; Fladby T
J Proteome Res; 2015 Nov; 14(11):4834-43. PubMed ID: 26452689
[TBL] [Abstract][Full Text] [Related]
6. A selected reaction monitoring (SRM)-based method for absolute quantification of Aβ38, Aβ40, and Aβ42 in cerebrospinal fluid of Alzheimer's disease patients and healthy controls.
Pannee J; Portelius E; Oppermann M; Atkins A; Hornshaw M; Zegers I; Höjrup P; Minthon L; Hansson O; Zetterberg H; Blennow K; Gobom J
J Alzheimers Dis; 2013; 33(4):1021-32. PubMed ID: 23076076
[TBL] [Abstract][Full Text] [Related]
7. Quantitative analysis of amyloid beta peptides in cerebrospinal fluid of Alzheimer's disease patients by immunoaffinity purification and stable isotope dilution liquid chromatography/negative electrospray ionization tandem mass spectrometry.
Oe T; Ackermann BL; Inoue K; Berna MJ; Garner CO; Gelfanova V; Dean RA; Siemers ER; Holtzman DM; Farlow MR; Blair IA
Rapid Commun Mass Spectrom; 2006; 20(24):3723-35. PubMed ID: 17117458
[TBL] [Abstract][Full Text] [Related]
8. Reference measurement procedure for CSF amyloid beta (Aβ)
Pannee J; Portelius E; Minthon L; Gobom J; Andreasson U; Zetterberg H; Hansson O; Blennow K
J Neurochem; 2016 Nov; 139(4):651-658. PubMed ID: 27579672
[TBL] [Abstract][Full Text] [Related]
9. Method comparison study of the Elecsys® β-Amyloid (1-42) CSF assay versus comparator assays and LC-MS/MS.
Shaw LM; Hansson O; Manuilova E; Masters CL; Doecke JD; Li QX; Rutz S; Widmann M; Leinenbach A; Blennow K
Clin Biochem; 2019 Oct; 72():7-14. PubMed ID: 31129181
[TBL] [Abstract][Full Text] [Related]
10. Quantification of Alzheimer amyloid beta peptides ending at residues 40 and 42 by novel ELISA systems.
Jensen M; Hartmann T; Engvall B; Wang R; Uljon SN; Sennvik K; Näslund J; Muehlhauser F; Nordstedt C; Beyreuther K; Lannfelt L
Mol Med; 2000 Apr; 6(4):291-302. PubMed ID: 10949910
[TBL] [Abstract][Full Text] [Related]
11. Round robin test on quantification of amyloid-β 1-42 in cerebrospinal fluid by mass spectrometry.
Pannee J; Gobom J; Shaw LM; Korecka M; Chambers EE; Lame M; Jenkins R; Mylott W; Carrillo MC; Zegers I; Zetterberg H; Blennow K; Portelius E
Alzheimers Dement; 2016 Jan; 12(1):55-9. PubMed ID: 26206625
[TBL] [Abstract][Full Text] [Related]
12. Amyloid-β 42/40 cerebrospinal fluid concentration ratio in the diagnostics of Alzheimer's disease: validation of two novel assays.
Lewczuk P; Lelental N; Spitzer P; Maler JM; Kornhuber J
J Alzheimers Dis; 2015; 43(1):183-91. PubMed ID: 25079805
[TBL] [Abstract][Full Text] [Related]
13. Qualification of a surrogate matrix-based absolute quantification method for amyloid-β₄₂ in human cerebrospinal fluid using 2D UPLC-tandem mass spectrometry.
Korecka M; Waligorska T; Figurski M; Toledo JB; Arnold SE; Grossman M; Trojanowski JQ; Shaw LM
J Alzheimers Dis; 2014; 41(2):441-51. PubMed ID: 24625802
[TBL] [Abstract][Full Text] [Related]
14. Quantitative Measurement of Cerebrospinal Fluid Amyloid-β Species by Mass Spectrometry.
Seino Y; Nakamura T; Harada T; Nakahata N; Kawarabayashi T; Ueda T; Takatama M; Shoji M
J Alzheimers Dis; 2021; 79(2):573-584. PubMed ID: 33337370
[TBL] [Abstract][Full Text] [Related]
15. Quantitation of amyloid beta peptides Aβ(1-38), Aβ(1-40), and Aβ(1-42) in human cerebrospinal fluid by ultra-performance liquid chromatography-tandem mass spectrometry.
Lame ME; Chambers EE; Blatnik M
Anal Biochem; 2011 Dec; 419(2):133-9. PubMed ID: 21888888
[TBL] [Abstract][Full Text] [Related]
16. An LC-MS/MS-based platform for the quantification of multiple amyloid beta peptides in surrogate cerebrospinal fluid.
Oztug M; Vatansever B; Altin G; Akgoz M; Can SZ
J Mass Spectrom Adv Clin Lab; 2024 Jan; 31():40-48. PubMed ID: 38375485
[TBL] [Abstract][Full Text] [Related]
17. Reference measurement procedures for Alzheimer's disease cerebrospinal fluid biomarkers: definitions and approaches with focus on amyloid β42.
Mattsson N; Zegers I; Andreasson U; Bjerke M; Blankenstein MA; Bowser R; Carrillo MC; Gobom J; Heath T; Jenkins R; Jeromin A; Kaplow J; Kidd D; Laterza OF; Lockhart A; Lunn MP; Martone RL; Mills K; Pannee J; Ratcliffe M; Shaw LM; Simon AJ; Soares H; Teunissen CE; Verbeek MM; Umek RM; Vanderstichele H; Zetterberg H; Blennow K; Portelius E
Biomark Med; 2012 Aug; 6(4):409-17. PubMed ID: 22917143
[TBL] [Abstract][Full Text] [Related]
18. Simultaneous analysis of cerebrospinal fluid biomarkers using microsphere-based xMAP multiplex technology for early detection of Alzheimer's disease.
Kang JH; Vanderstichele H; Trojanowski JQ; Shaw LM
Methods; 2012 Apr; 56(4):484-93. PubMed ID: 22503777
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of peptide adsorption-controlled liquid chromatography-tandem mass spectrometric (PAC-LC-MS/MS) method for simple and simultaneous quantitation of amyloid β 1-38, 1-40, 1-42 and 1-43 peptides in dog cerebrospinal fluid.
Goda R; Kobayashi N
J Chromatogr B Analyt Technol Biomed Life Sci; 2012 May; 895-896():137-45. PubMed ID: 22503736
[TBL] [Abstract][Full Text] [Related]
20. Performance Evaluation of an Automated ELISA System for Alzheimer's Disease Detection in Clinical Routine.
Chiasserini D; Biscetti L; Farotti L; Eusebi P; Salvadori N; Lisetti V; Baschieri F; Chipi E; Frattini G; Stoops E; Vanderstichele H; Calabresi P; Parnetti L
J Alzheimers Dis; 2016 Jul; 54(1):55-67. PubMed ID: 27447425
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
